购物车
- 全部删除
- 您的购物车当前为空
Polatuzumab 是一种靶向 CD79b 的单克隆抗体,可携带化疗活性分子。Polatuzumab 粘附在 CD79b 蛋白上并将化疗活性分子转运到细胞中用来杀死细胞。Polatuzumab 可用于合成抗体-化合物偶联物 Polatuzumab Vedotin。
为众多的药物研发团队赋能,
让新药发现更简单!
Polatuzumab 是一种靶向 CD79b 的单克隆抗体,可携带化疗活性分子。Polatuzumab 粘附在 CD79b 蛋白上并将化疗活性分子转运到细胞中用来杀死细胞。Polatuzumab 可用于合成抗体-化合物偶联物 Polatuzumab Vedotin。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,300 | 现货 | |
5 mg | ¥ 3,250 | 现货 | |
10 mg | ¥ 4,750 | 现货 | |
25 mg | ¥ 7,480 | 现货 | |
50 mg | ¥ 9,870 | 现货 | |
100 mg | ¥ 13,600 | 5日内发货 |
产品描述 | Polatuzumab is a monoclonal antibody that targets CD79b and carries chemotherapeutically active molecules.Polatuzumab adheres to CD79b proteins and transports the chemotherapeutically active molecules into cells to kill them.Polatuzumab can be used to synthesize the antibody-compound coupling, Polatuzumab Vedotin. |
别名 | 维泊妥珠单抗 |
分子量 | Approximately 145.24 kDa |
CAS No. | 2279068-37-8 |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.